- Home
- RNAC vs OM Comparison
RNAC vs OM Comparison
Compare RNAC & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- OM
- Stock Information
- Founded
- RNAC 2007
- OM 2003
- Country
- RNAC United States
- OM United States
- Employees
- RNAC N/A
- OM N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RNAC Health Care
- OM Health Care
- Exchange
- RNAC Nasdaq
- OM Nasdaq
- Market Cap
- RNAC 276.3M
- OM 220.8M
- IPO Year
- RNAC 2016
- OM 2020
- Fundamental
- Price
- RNAC $10.05
- OM $13.91
- Analyst Decision
- RNAC Strong Buy
- OM Hold
- Analyst Count
- RNAC 4
- OM 1
- Target Price
- RNAC $40.00
- OM $22.00
- AVG Volume (30 Days)
- RNAC 48.4K
- OM 288.8K
- Earning Date
- RNAC 08-07-2025
- OM 08-06-2025
- Dividend Yield
- RNAC N/A
- OM N/A
- EPS Growth
- RNAC N/A
- OM N/A
- EPS
- RNAC N/A
- OM N/A
- Revenue
- RNAC $1,026,000.00
- OM $119,304,000.00
- Revenue This Year
- RNAC N/A
- OM $12.37
- Revenue Next Year
- RNAC N/A
- OM $10.52
- P/E Ratio
- RNAC N/A
- OM N/A
- Revenue Growth
- RNAC N/A
- OM 2.47
- 52 Week Low
- RNAC $8.46
- OM $5.85
- 52 Week High
- RNAC $26.50
- OM $25.35
- Technical
- Relative Strength Index (RSI)
- RNAC 34.71
- OM 43.41
- Support Level
- RNAC $10.50
- OM $13.60
- Resistance Level
- RNAC $11.80
- OM $14.35
- Average True Range (ATR)
- RNAC 0.56
- OM 0.60
- MACD
- RNAC -0.11
- OM 0.26
- Stochastic Oscillator
- RNAC 0.45
- OM 80.09
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.